Literature DB >> 8083638

Seeing morphemes: loss of visibility during the retinal stabilization of compound and pseudocompound words.

A W Inhoff1, R Topolski.   

Abstract

When stabilized, a retinal image fades from vision. Earlier studies suggested that knowledge constrains the loss of vision, as disappearing images fragment into familiar subpatterns. Effects of image stabilization on word perception were used in the current study to examine effects of morphemic knowledge on stimulus fragmentations. Bimorphemic compound words (in which beginning and ending trigrams formed morphemic subword units) and monomorphemic pseudo-compound words (with a similar trigram structure) were stabilized. Stimulus fragmentations generally resulted in the visibility of lexically nondistinct strings of letters. However, internal morpheme boundaries also affected the loss of vision when compound words were stabilized. Two follow-up experiments indicated that morpheme-related loss of vision was neither the result of differential forgetting rates nor of guessing bias.

Entities:  

Mesh:

Year:  1994        PMID: 8083638     DOI: 10.1037//0096-1523.20.4.840

Source DB:  PubMed          Journal:  J Exp Psychol Hum Percept Perform        ISSN: 0096-1523            Impact factor:   3.332


  4 in total

1.  Eye position changes during reading fixations are spatially selective.

Authors:  Albrecht W Inhoff; Matthew S Solomon; Bradley A Seymour; Ralph Radach
Journal:  Vision Res       Date:  2008-03-03       Impact factor: 1.886

2.  Eye movements during the reading of compound words and the influence of lexeme meaning.

Authors:  Albrecht W Inhoff; Matthew S Starr; Matthew Solomon; Lars Placke
Journal:  Mem Cognit       Date:  2008-04

3.  Compound word effects differ in reading, on-line naming, and delayed naming tasks.

Authors:  A W Inhoff; D Briihl; J Schwartz
Journal:  Mem Cognit       Date:  1996-07

4.  Loss of vision during the retinal stabilization of letters.

Authors:  R Topolski; A W Inhoff
Journal:  Psychol Res       Date:  1995
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.